About ONCOTAB, INC.
OncoTAb, Inc. is a company focused on developing innovative diagnostic and therapeutic products for cancer, particularly targeting the tumor form of MUC1 (tMUC1) for early detection and treatment. Their flagship product is the Agkura® Personal Score, a blood test designed to aid in breast cancer detection in women with dense breast tissue.
Development of blood tests for cancer detectionCreation of targeting agents for tumor localization using PET/SPECT scansDevelopment of cytotoxic agents for targeted cancer treatmentResearch and commercialization of novel cancer diagnostic and therapeutic products
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ONCOTAB, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.